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Background: Hypoxia pulmonary arterial hypertension (HPAH) is a disease of the small
vessels characterized by sustained vasoconstriction, thickening of arterial walls, vascular
remodeling, and progressive increase in pulmonary vascular resistance, thus leading to
right heart failure and finally death. Recent evidence demonstrated that massive pul-
monary artery smooth muscle-like cells (PASMLCs) accumulating in the intima might also
be developed from the differentiation of pulmonary myofibroblast (PMF) of tunica media.
And PMF appeared the phenomenon of the cytoskeleton remodeling. So, it would be
important in the clarification of the pivotal factors controlling this cytoskeleton structure
change.
Methods: PMFs were cultured from the normal rats and then divided into three groups
and incubated by normal or hypoxic conditions respectively. mRNA level was evaluated
by real-time reverse transcription polymerase chain reaction, and protein expression was
detected by western blot. Cell proliferation was determined by the MTT and thymidine
incorporation assay.
Results: Here, we report that the hypoxia increased the expression levels of ezrin mRNA
and protein in PMFs, which might explain that the expression of cytoskeletal proteins
(destrin, a1-actin, and a1-tubulin) in PMFs was significantly induced by hypoxia. After inhibit-
ing ezrin in PMFs by siRNA transfection, we found the over-expression of cytoskeletal
proteins induced by hypoxia was significantly suppressed at all time-points. Additionally,
we found that hypoxia or over-expression of ezrin through adenovirus-mediated ezrin gene
transfection significantly increases the proliferation and migration of PMFs, and which could
be inverted by the transfection of siRNA.
Conclusion: These findings suggest that ezrin regulating of aberrant dysregulation of
cytoskeletal proteins may be the major cause of PMFs’ proliferation and migration under
the condition of hypoxia and may, therefore, play a fundamental role in the accumulation
of PASMLCs of HPAH.
Keywords: pulmonary myofibroblast, hypoxia, ezrin, cell proliferation, pulmonary vascular remodeling, pulmonary
artery smooth muscle-like cells
INTRODUCTION
Hypoxia pulmonary arterial hypertension (HPAH) is a dis-
ease of the small pulmonary arteries characterized by sustained
Abbreviations: 3H-TdR, tritiated thymidine; Ad, adenovirus; Ad-ezrin, adenovirus-
mediated ezrin gene; COPD, chronic obstructive pulmonary disease; ERM,
ezrin/radixin/moesin; F-MF, fibroblast to myofibroblast; GFP, green fluorescent
protein; HPAH, hypoxia pulmonary arterial hypertension; MFs, myofibroblasts;
MOI, multiplicity of transduction; NF2, neurofibromatosis type II; PASMLCs,
pulmonary artery smooth muscle-like cells; PMF, pulmonary myofibroblast;
PMFs, pulmonary myofibroblasts; PMVECs, pulmonary microvascular endothelial
cells.
vasoconstriction, thickening of aortic wall, vascular remodel-
ing, and progressive increase in pulmonary vascular resistance,
thus leading to right heart failure and finally death (1–3). It has
been proven that the massive accumulation of pulmonary artery
smooth muscle-like cells (PASMLCs) in the vascular intima is likely
the major reason resulting in arterial remodeling and vascular
lumen narrowing, and thus it is the main cause of cor pulmonale
in chronic obstructive pulmonary disease (COPD) (4). Although
some early studies suggested that this massive cell accumulation
in the intima just stemmed from the proliferation and migra-
tion of PASMCs in tunica media, recent evidence demonstrated
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that massive PASMLCs accumulating in the intima might also be
developed from the differentiation of pulmonary myofibroblasts
(PMFs) of tunica media (5).
Myofibroblasts (MFs) were first described in experimental
wound healing by observation method of electron microscopy, as
fibroblastic cells located within granulation tissue and exhibiting
bundles of microfilaments (6). Since then, evidence from many
laboratories has indicated that MFs play a pivotal role in tissue
repair and remodeling; moreover, they are a key player in different
pathological conditions such as hypertrophic scars, fibromatosis,
systemic sclerosis, organ fibrosis, and stroma reaction to epithe-
lial tumors (7–11). In all forms of pulmonary hypertension, the
early appearance of adventitial PMFs is an event that precedes
intimal and medial changes. Here, an important factor leading
to pulmonary hypertension is hypoxia, which is recognized as a
critical factor in vascular remodeling. During hypoxia-mediated
pulmonary hypertension, hypoxia can induce fibroblast to myofi-
broblast (F-MF) transition, and also stimulate the production of
growth factors and cytokines, such as transforming growth factor-
β, thrombin, endothelin (12, 13). In addition, as a major down-
stream of hypoxia effect, adventitial cells expressing mesenchymal
stem cell markers could be a source of MFs and contribute to
arterial remodeling (14). Taken together, the role of MFs in the
pathogenesis of HPAH has thus drawn more and more attention
by researchers. However, the molecular mechanism of hypoxia-
induced MF differentiation for PASMLCs is unclear and thus
demands further study.
Because hypoxia-induced pulmonary vessel remodeling is often
associated with the remodeling of cytoskeleton structure, it will
be not only interesting but also important in the clarification of
the pivotal factors controlling this cytoskeleton structure change.
Ezrin, a cellular protein initially isolated as a cytoskeletal compo-
nent of intestinal microvilli and a substrate for tyrosine kinase,
shows 77, 73, and 43% homology with three other proteins,
radixin, moesin, and merlin encoded by neurofibromatosis type
II (NF2) tumor suppressor gene. These molecules comprise the
ezrin/radixin/moesin (ERM) family. ERM proteins, a group of
band 4.1 superfamily, act as linker proteins that interact with
many cytoskeleton such as a1-actin, a1-tubulin, F1-action, and
destrin. However, the absolute different properties of ezrin and
merlin could influence cell proliferation and function (15–18).
Ezrin is the essential molecule that stimulates proliferation and
migration, whereas merlin is the molecule that inhibits cell prolif-
eration of many cancer cells from PASMCs, pulmonary microvas-
cular endothelial cells (PMVECs), and fibroblast, all of which are
involved in the hypoxia-induced pulmonary vessel remodeling at
the same time (19, 20). Therefore, it has been proposed that ezrin
might be probably involved in the different regulatory processes in
hypoxia-induced PASMLCs proliferation and migration. However,
there is no definitive evidence for this assertion.
In the present study, we demonstrate that ezrin protein medi-
ates proliferation and migration of MFs via regulating their
cytoskeletal remodeling. We found that over-expression or silence
of ezrin protein increase or decrease the expression of cytoskele-
tal proteins in human MF respectively. More importantly, as our
hypothesis that MFs might be also involved in the cell prolifera-
tion and migration induced by hypoxia, we observed that hypoxia
can strongly induce the expression of ezrin, which mediates the
hypoxia-induced growth and migration of MFs as well as the
expression control of several cytoskeleton proteins involved in
vessel remodeling.
MATERIALS AND METHODS
REAGENTS
Rat MF line, built in our lab and used in our initial studies
were cultured in low glucose Dulbecco’s modified Eagle’s medium
(DMEM) (PAA, USA) supplied with 10% fetal calf serum (FCS)
(HyClone, USA), as previously described (21). A rabbit polyclonal
anti-ezrin antibody, a rabbit polyclonal anti-MHC antibody, a
rabbit polyclonal anti-calponin antibody, a rabbit polyclonal anti-
ezrin antibody were bought from NeoMarkers company of USA.
ADENOVIRUS TRANSDUCTION
Inoculated PMFs of a similar concentration (106/cm2) were
divided into a transduced group, a non-transduced group, and
an empty vector group. Each group had the following treatments:
normoxia (T 0), 24 h (T 1), and 48 h (T 2) treatment with 3% O2.
When these cells were 80% confluent, the original serum was
replaced with 0.1% FCS.
The recombinant adenovirus (Ad) that carried the full-length
cDNA of the ezrin gene and green fluorescent protein (GFP)
was constructed in our previous study. After 24 h of synchronous
growth, the PASMCs received the hypoxia treatment. In addition,
24 h prior to treatment, adenovirus-mediated ezrin gene (Ad-
ezrin) with a multiplicity of transduction (MOI) of 60 was added
to the medium of the Ad-ezrin-transduced group. Subsequently,
these cells were placed upside-down under an immunofluores-
cence microscope to determine transduction efficiency.
IMMUNOFLUORESCENCE MICROSCOPY
Pulmonary myofibroblasts were plated at concentration of
2× 105 cells/ml on glass coverslips and allowed to be adherent
overnight. Coverslips were then washed with PBS and fixed in 4%
paraformaldehyde for 15 min. After being permeabilized in 0.5%
Triton X-100 for 15 min at room temperature, cells were washed
by PBS and incubated at 4°C overnight in PBS (PH 7.0) containing
1% bovine serum album with rabbit anti-human ezrin antibody
or control 10% goat serum (Biostar, Wuhan, China). After that,
cells were washed three times by PBS and incubated at 4°C for 1 h
with antirabbit IgG conjugated to TRITC (Biostar). Nuclei were
stained by 4′,6-diamidino-2-phenylindole (DAPI). After the final
wash, cells were mounted and then visualized using an Olympus
fluorescent microscope.
REAL-TIME RT-PCR ANALYSIS
Total RNA was processed using Tripure kits to perform the reverse
transcription (RT)-polymerase chain reaction (PCR) experi-
ments. RT was performed with 2µg RNA, Oligo (dT) 15 (Sangon,
China), dNTP (Sangon, China), and the reaction buffer supplied
with M-MLV reverse transcriptase (Promega, USA). The fluo-
rescence intensity ratio of the target gene to GAPDH was used
as a measure of the relative gene expression. The PCR ampli-
fication reaction conditions were as follows: 94°C 1 min, 59°C
30 s, 72°C 1 min in 32 cycles. Specific primer sequences were
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used for the amplification of ezrin (forward primer: 5′-GTGG
GATGCTCAAAGATAATGC-3′; reverse primer: 5′-CACCTCGATG
GTGTCAGGCT-3′; 375 bp) (22), and GAPDH (forward primer:
5′-TGGAGTCCACTGGCGTCTTCAC-3′; reverse primers: 5′-
CATGAGGTCCACCAGCCCTGTTG-3′; 698 bp). After amplifica-
tion, 10µl of PCR product was used for electrophoresis on a 1.5%
agarose gel, whose result was scanned by an Alpha Imager (set as
a gray scale). The experiment was performed independently four
times.
WESTERN BLOT
Cells were harvested under the described conditions and lysed
in a RIPA buffer (0.5% Non-idet P-40, 10 mM Tris, pH 7.4,
150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4) with a protease
inhibitor (1 mM PMSF). The BCA protein assay was used to quan-
tify protein. Briefly, after Mix reagents, sample were added and
incubated for 30 min and read at 562 nm. Equal quantities of pro-
tein were loaded for sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). Following transfer to PVDF mem-
branes, samples were incubated with primary antibody (1:1000
dilution) at 37°C for 1 h or overnight at 4°C. The membrane was
washed twice with TBS, and the bound antibody was detected
using an IgG-HRP secondary antibody (1:500 dilution) for 30 min.
Blots were detected using an enhanced chemiluminescence sys-
tem (Amersham, UK). Another membrane prepared by the
same protocol was probed with anti-GADPH antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) to normalize sample
loading.
RNA INTERFERENCE
siRNA was used to knock down ezrin in the human PASMCs.
Non-silenced and siControl human PASMCs were used as con-
trol. The sequence of siRNAs were siRNA-ezrin 1 (5′-GGACACU
UGGAUUUUUUUUtt-3′), siRNA-ezrin 2 (5′-GGUGGUAAAGA
CUAUCGGCtt-3′), siRNA-ezrin 3 (5′-GGAUUUCCUACCUGGC
UGtt-3′) (22). An electroporation instrument (Bio-Rad, Hercules,
USA) was employed for transfection. Briefly, 400µl of human
PASMCs (2.5× 106 cells/ml cold EBM-2) together with 1.4µg
siRNA were added into a prechilled electrode gap cuvette (Bio-
Rad). Then, the cuvette was inserted into an electrotransfer chan-
nel. After cells were shocked once using square wave 250 V for
1 min, the cuvette was taken out immediately and 0.5 ml of com-
plete medium EGM-2 pre-warmed at 37°C was added. Finally, cells
were seeded into six-well culture plates and incubated at 37°C in
a humidified 5% CO2 chamber.
PMFs MIGRATION ASSAY
Migration assays were performed using the scratch wound motil-
ity assay. MFs were seeded in six-well plates (1.50× 105 cells/well)
and grown to confluence. Twenty-four hours after serum depriva-
tion, cells from each group were mounted on a reusable template
to create a standard wound (<3 mm). Wound closure rate was
followed with a reference point in the field of the wound at the
bottom of the plate by direct microscopic visualization. The pro-
cedure permitted the imaging of the identical spot each time. The
remaining cell-free area was determined via microphotography
that was performed 24 h after injury.
TRITIATED THYMIDINE INCORPORATION ASSAY
Cells with 2× 104/ml were inoculated in a 96-well culture plate.
Each phase had three wells that were cultured for 2 days before
hypoxia treatment. One microcurie tritiated thymidine (3H-TdR;
1µCi/well) was added to each well 6 h prior to the end of the
culturing phase. Subsequently, the culture was stopped at the
proper phase, and the medium was removed. The incorpora-
tion was stopped with cold PBS solution. The cells were digested
with 0.25% trypsin and collected on a glass fiber filter with a
multi-head harvester. Cells were washed three times with physi-
ological saline stabilized with 10% trichloroacetic acid, destained
with absolute ethanol, dried for 30 min at 80°C, transferred into
scintillation fluid, and counted in a liquid scintillation counter
(counts/min, cpm).
MTT ASSAY
Cells between 103 and 104 were inoculated into each well in a
96-well plate. The plate was placed in 5% CO2 and cultured for
24 h. Each group received the appropriate treatment for its specific
experimental condition. The plate was cultured for an additional
24 h after replacing the medium with a serum-free medium. Next,
20µl MTT solution (5 mg/ml) was added, and the plate was inoc-
ulated for 4 h at 37°C. The supernatant from each well was then
carefully discarded. Finally, 150µl DMSO was added to each well,
and the crystals were fully dissolved using 10 min oscillations. The
absorbance value of each well was measured using an ELISA reader
with 490 nm as the test wave length and 280 nm as the reference
wave length.
STATISTICAL ANALYSIS
All data are represented as means± SEM. Comparisons between
groups were performed using a Student’s t -test or a Mann–
Whitney U -test for parametric or non-parametric tests, respec-
tively. The results were considered statistically significant when
p< 0.05.
RESULTS
HYPOXIA INDUCED THE PROLIFERATION AND MIGRATION OF PMFs
To test the effect of cell proliferation by hypoxia treatment, we
used the 3H-TdR incorporation assay and MTT assay to mea-
sure the rate of DNA synthesis and cell proliferation, respectively.
PMFs under hypoxia condition exhibited significantly higher
DNA synthesis than those cultured under normoxia condition
at each time-point measured (Figure 1A). Similarly, the rate of
PMFs proliferation was strongly induced under hypoxia condi-
tion compared with the control normoxia status (Figure 1B). In
addition, hypoxia prominently enhanced the migrating ability of
PMFs (Figure 1C). Taken together, all these results demonstrated
that hypoxia treatment positively promoted the proliferation and
migratory ability of PMFs.
HYPOXIA ENHANCED THE EXPRESSION OF EZRIN GENE AND
CYTOSKELETON PROTEINS IN PMFs
Our following question is which factor(s) might be involved
in the control of the induced cell proliferation and migra-
tion of PMFs. Here, we focused on some cytoskeleton targets
because cytoskeleton protein levels and structure change are often
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FIGURE 1 | Hypoxia markedly enhanced PMFs proliferation and
migration. (A) DNA synthesis was assessed by a 3H-TdR incorporation
assay. (B) Cell viability was measured using an MTT assay. (C) Cell migration
ability was assessed by scratch wound motility assay. The distance of cell
migration in all groups and time-points is displayed. Each data point
represents the mean±SEM of four independent experiments. *p<0.05 vs.
normoxia condition;T 0–2: MFs were treated with normoxia or hypoxia
condition for 0 h (T 0), 24 h (T 1), 48 h (T 2), respectively.
observed during HPAH process. Consistent with our hypothe-
sis, hypoxia treatment significantly increased the gene expres-
sion of ezrin, compared with normoxia treatment. The relative
expression of ezrin mRNA under hypoxia condition was signif-
icantly higher than in that under normoxia condition at dif-
ferent time-points (Figures 2A,B). We also detected the similar
induction of ezrin protein expression in PMFs under treatment
with hypoxia.
Interestingly and consistently, exposure in hypoxia condition
significantly increased the expression of several cytoskeleton pro-
teins such as a1-actin, a1-tubulin, and destrin (Figure 2C). Thus, it
indicates that ezrin might be a critical factor that can be induced by
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FIGURE 2 | Levels of ezrin mRNA and protein in PMFs induced by
hypoxia at each time-point. Exposure to hypoxia condition significantly
increased expression of the ezrin gene, including the transcript and protein
levels in PMFs (p<0.05). (A) The electropherogram of western blotting.
(B) The electropherogram of RT-PCR. (C) The density of the expression of
mRNA and protein of ezrin compared with GAPDH is displayed. Each data
point represents the mean±SEM of four independent experiments.
*p<0.05 vs. normoxia.
hypoxia to result in the strong induction of cytoskeleton structure
observed in HPAH disease.
AD-EZRIN EFFECTIVELY UP-REGULATED EZRIN TRANSCRIPTION AND
PROTEIN EXPRESSION IN PMFs AND siRNA EFFECTIVELY
DOWN-REGULATED EZRIN PROTEIN EXPRESSION INDUCED BY
HYPOXIA
To test whether the respective change of ezrin expression might
affect the cell proliferation and migration of PMFs, we intro-
duced either ectopic ezrin-expressing PMFs or ezrin-depleting
PMFs. After virus transduction with GFP-tagged ezrin, bright
green fluorescence was observed in the cytoplasm and nuclei of
more than 95% cells (Figure 3A). Compared with non-transduced
or empty vector-transduced control PMFs, in both of which
low ezrin transcript and protein expression levels were detected,
ezrin-GFP-transduced PMFs showed a significant increase in both
transcription and protein levels (Figure 3B).
In the opposite case, we transfected the SiRNA targeting ezrin
to knock down the gene and protein expression of endoge-
nous ezrin in PMFs. At 48 h after siEzrin transfection, there was
no significant difference in the expression of ezrin between the
siControl and the mock control groups, while we observed a
remarkable reduction of both ezrin gene and protein levels in
siEzrin-expressing PMFs. More importantly, the knockdown of
ezrin strongly blocked the respective induction of ezrin by hypoxia
treatment (Figure 3C).
OVER-EXPRESSION OF EZRIN GENE IN NORMOXIA CONDITION
STIMULATED THE PROLIFERATION AND MIGRATION OF PMFs
Firstly, we used our ezrin-transduced PMFs tested above
(Figures 3A,B) to test whether over-expression of ezrin in
PMFs under the normoxia condition could phenotype the cell
proliferation and migration ability enhanced by hypoxia treat-
ment. Ezrin-overexpressing PMFs under normoxia condition
exhibited the significant increase of both DNA synthesis and cell
proliferation levels, compared with group mock-vector and non-
transduction PMFs (Figures 4A,B). Moreover, we also detected
the prominently enhanced cell migration ability by the over-
expression of ezrin in PMFs (Figure 4C). Taken together, all these
results indicate that the enhanced levels of ezrin gene and protein
expression under hypoxia could account for the respective increase
of cell proliferation and migration in HPAH.
SILENCING EZRIN PROTEIN EXPRESSION INHIBITED THE
PROLIFERATION AND MIGRATION OF PASMCs INDUCED BY HYPOXIA
OR AD-EZRIN
To further confirm whether this hypoxia-enhanced expression of
ezrin definitely led to the significant increase of cell prolifera-
tion and migration ability, we used the ezrin SiRNA-expressing
PMFs that we already tested in the knockdown efficiency above
(Figure 3C). DNA synthesis, cell proliferation, and migration
levels were significantly inhibited in PMFs with ezrin SiRNA
expression compared to the siControl or mock control cells
(Figures 5A–C).
SILENCING EZRIN PROTEIN EXPRESSION INVERTED THE CHANGE OF
CYTOSKELETON PROTEINS INDUCED BY HYPOXIA
We have already shown that exposure under hypoxia condition
significantly increased the protein expression of a1-actin, a1-
tubulin, and destrin cytoskeleton factors (Figures 6A,B), which
indicates that this potential induction of cytoskeleton proteins
and structure might be involved in tissue modeling involved in
HPAH disease. Our final question is whether these enhanced
cytoskeleton protein levels could stem from ezrin which can be
www.frontiersin.org March 2015 | Volume 2 | Article 10 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yi et al. Ezrin regulating myofibroblast cytoskelaton remodelling
FIGURE 3 | Ad-ezrin transfected into PMFs was strongly expressed
and the protein was found in the PMFs. And the expression of Ezrin
was successfully down-regulated in PMFs by siRNA. (A) At 24 h after
transfection with Ad-ezrin, PMFs had a normal structure with no
observable pathological characteristics (magnification 40×). Bright green
fluorescence was observed in nearly all cells using an inverted
fluorescence microscope following transfection with Ad-ezrin containing
the green fluorescent protein (GFP) gene (magnification 40×). (B) The
expression of the ezrin mRNA and protein in PMFs 24 h in each group
was determined by RT-PCR and western blotting. GAPDH was used as
an internal control. (C) The expression of ezrin was successfully
down-regulated in siRNA. PMFs were incubated with normoxia or
hypoxia treated concurrently with siRNA. Ezrin transcription level
dramatically diminished after 48 h of transfection compared with levels in
the siControl and mock control groups. Following 48 h transfection, the
protein expression of ezrin was strongly suppressed by ezrin siRNA.
Each data point represents the mean±SEM of four independent
experiments. *p<0.05; Non-T, non-transfection with Ad-ezrin; empty-T,
empty vector transfection; T, transfection with Ad-ezrin; Group N,
normoxia condition; Group H, hypoxia condition.
prominently induced by hypoxia status. Knockdown of ezrin in
PMFs under hypoxia treatment completely inhibited the induction
of these three cytoskeleton proteins under hypoxia condition
(Figures 6A–C), confirming our hypothesis.
DISCUSSION
It is currently believed that the accumulation of mass PASMLCs
in the vascular intima is likely the major reason leading to arterial
remodeling and vascular lumen narrowing. Although some early
studies suggested that the accumulation of mass PASMLCs in the
intima is just from the migration and proliferation of PASMCs in
tunica media, recent evidence showed that mass PASMLCs accu-
mulating in the intima are differentiated from PMF of tunica
media too (12). Previous studies have shown that exposure of
lung fibroblasts to hypoxia stimulates the fibroblast proliferation
and its differentiation into PMFs (8, 12, 23). More importantly,
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FIGURE 4 | Over-expression of ezrin protein induced by Ad-ezrin
significantly enhanced the proliferation and migration of PMFs,
just like hypoxia. (A) DNA synthesis was assessed by a 3H-TdR
incorporation assay. (B) Cell viability was measured using an MTT
assay. (C) Cell migration ability was assessed by scratch wound
motility assay. The distance of cell migration in all groups and
time-points is displayed. Each data point represents the mean±SEM
of four independent experiments.*p<0.05 vs. T; non-T,
non-transfection with Ad-ezrin; empty-T, empty vector transfection; T,
transfection with Ad-ezrin.
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FIGURE 5 | Silencing ezrin protein expression inhibited the
proliferation and migration of PMFs induced by hypoxia or
ad-ezrin. (A) DNA synthesis was assessed by a 3H-TdR incorporation
assay. (B) Cell viability was measured using an MTT assay. (C) Cell
migration ability was assessed by scratch wound motility assay. The
distance of cell migration in all groups and time-points is displayed.
Each data point represents the mean±SEM of four independent
experiments.*p<0.05.
PMFs characteristically synthesize α-SMA, a most commonly used
molecular marker, which contributes to stronger contractile activ-
ity. Contractile PMFs are responsible for the irreversible alter-
ations of the lung parenchyma that result in accumulation of stiff
scar tissue, ultimately leading to deterioration of lung function
(13, 23, 24).
In the present study, we firstly demonstrated that the expres-
sion of cytoskeletal proteins, including a1-actin, a1-tubulin, and
destrin in PMFs is up-regulated significantly under hypoxic
condition compared to normoxia status. This suggested that
hypoxia promotes the differentiation of PMFs to be a kind of
PASMLCs. Combined with previous finding, it indicated that
hypoxia might stimulate the transformation of lung fibroblasts
into PMFs, and further develop the PMFs into one subgroup of
PASMLCs.
Secondly, our work strongly clarified the underlying mecha-
nism for this hypoxia-induced PMFs transformation which has
been unclear for a long time. It has been well-known that TGF-β1
induces the PMFs cell transformation and the cytoskeleton pro-
teins synthesis critical for the formation of PASMLCs. Notably,
we have previously reported that hepatopulmonary syndrome’s
rat serum induces PMVECs to differentiate into PASMLCs, dur-
ing which the TGF-β1/Smads signal and annexin A1/A2 proteins
might play a key role in this differentiation and transformation of
PASMLCs (25). However, the molecular mechanism of hypoxia-
induced fibroblast-to-PMFs and the cytoskeletal remodeling in
it is kept unknown. Here, our study demonstrated that ezrin,
a critical cytoskeleton protein, plays critically important role in
this process. Our finding is highly consistent with many previ-
ous studies that multiple cells including PASMCs, PMVECs, and
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FIGURE 6 |The expression change of cytoskeleton proteins,
including α1-actin, a1-tubulin, and destrin in myofibroblast was
up-regulated significantly under hypoxic conditions, and this
up-regulation was blocked by the transduction of siEzrin. (A) The
electropherogram of the western blot analysis. GAPDH was used as an
internal control. (B) Quantification of western blots using densitometry
in Group siControl. (C) Quantification of western blots using
densitometry in Group siEzrin. Each data point represents the
mean±SEM of four independent experiments. *p<0.05 vs. normoxia
condition; #p<0.05 vs. group siControl.
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PMFs, involved in the key pathogenesis process of PVR (12, 23, 26,
27), show the prominent cytoskeleton remodeling when exposure
to hypoxia or other stimulators. And it strongly suggested that
ezrin functions as the core regulator of cytoskeleton remodeling
observed in all these kinds of cells, thus could be used as the new
suitable therapeutics target of diseases associated with vascular
remodeling.
Ezrin, one of the ezrin–radixin–moesin proteins, is involved in
the formation of cell membrane processes such as lamellipodia and
filopodia, and thus acts as a membrane–cytoskeleton linker (20).
Our results showed that ezrin protein can be significantly posi-
tively regulated by exposure to hypoxia, and this ezrin increase
accounts for the ability induction of proliferation and migration
of PMFs. Our findings suggested that ezrin protein might be a
key regulatory protein in the over-expression of cytoskeletal pro-
teins in PMFs and might control not only the hypoxia-induced
transformation of fibroblast-to-PMFs, but also the migration and
proliferation capability of PMFs. However, it is still unclear about
the relationship between the differentiation of PMFs and several
signaling pathway of factors such as TGF-β1 and annexin A1/2,
and the functional link between all these controlling signals and
factors.
In summary, our novel findings provided the evidence support-
ing the hypothesis that the ezrin-mediated cytoskeletal remodeling
strongly controls the MFs proliferation and migration induced
by hypoxia. Our future understanding of abnormal cytoskele-
tal remodeling and the endogenous regulatory machinery of the
cytokine signaling cascade will be useful to provide a basis for cir-
cumventing the process of vascular remodeling and the creation
of targeted therapies for diseases that are associated with vascular
remodeling.
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